Back
Full-text
Journal article

Multiple Eruptive Sebaceous Hyperplasia Secondary to Cyclosporin in a Patient with Bone Marrow Transplantation.

  • Cortés B Division of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland.
  • Kaya G Division of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland.
  • 2016-12-20
Published in:
  • Dermatopathology (Basel, Switzerland). - 2016
Bone marrow transplant
Cyclosporin
Face
Graft
Sebaceous hyperplasia
Transplantation
English Many cutaneous complications have been described in patients treated with cyclosporin. Alterations of the pilosebaceous unit such as hypertrichosis are particularly frequent. However, the occurrence of sebaceous hyperplasia is exceptional. These lesions seem to be specific to cyclosporin rather than secondary to immunosuppression. Here, we report an exceptional case of eruptive and disseminated sebaceous hyperplasia arising in a bone marrow transplant recipient only a few months after starting immunosuppressive treatment with cyclosporin.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/232935
Statistics
Document views: 26 File downloads:
  • Full-text: 0